Pyxis Oncology Inc. (PYXS)
1.47
0.03 (2.08%)
At close: Jan 15, 2025, 3:59 PM
1.47
0.00%
After-hours Jan 15, 2025, 04:38 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -73.79M | -120.72M | -75.97M | -12.83M | -2.77M |
| Depreciation & Amortization | 1.93M | 709.00K | 647.00K | 469.00K | n/a |
| Stock-Based Compensation | 16.95M | 15.76M | 6.44M | 44.00K | 28.00K |
| Other Working Capital | -8.16M | 12.83M | 2.03M | 1.73M | 213.00K |
| Other Non-Cash Items | -4.13M | 10.41M | 20.60M | -56.00K | -264.00K |
| Deferred Income Tax | n/a | n/a | 6.28M | n/a | n/a |
| Change in Working Capital | -11.66M | 4.50M | 6.68M | 2.29M | 505.00K |
| Operating Cash Flow | -70.71M | -89.33M | -35.33M | -10.08M | -2.24M |
| Capital Expenditures | -6.73M | -6.40M | -540.00K | -1.48M | n/a |
| Acquisitions | 6.66M | n/a | -50.00K | n/a | n/a |
| Purchase of Investments | -196.83M | n/a | -50.00K | n/a | n/a |
| Sales Maturities Of Investments | 92.05M | n/a | 50.05K | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -50 | n/a | n/a |
| Investing Cash Flow | -104.85M | -6.40M | -590.00K | -1.48M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -193.00K | 183.00K | 151.75M | 32.00K | 43.90M |
| Financial Cash Flow | 5.93M | 183.00K | 304.04M | 35.00K | 21.95M |
| Net Cash Flow | -169.63M | -95.55M | 268.13M | -11.53M | 19.72M |
| Free Cash Flow | -77.44M | -95.73M | -35.87M | -11.57M | -2.24M |